Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMISE: Oral vs Transdermal HRT in Postmenopausal Women
NCT02264743Phase 4Unknown
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Nov 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol + dydrogesterone in postmenopause, sponsored by Royal Brompton and Harefield hospitals. Status: unknown.
02
Drugs
estradiol + dydrogesterone
03
Conditions
postmenopause
Beyond the preview
Go deeper on NCT02264743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264743.